Nina Niu Sanford/utswmed.org
Jan 27, 2025, 18:37
Nina Niu Sanford: Multimodal treatment for optimizing immune response in mCRC
Nina Niu Sanford, Assistant Professor and Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s Hospital/Massachusetts General Hospital, posted on X:
“Save the best for last! My mentor Ted Hong discusses multimodal tx for optimizing immune response in mCRC.
Liver mets appear to decrease IO efficacy.
Look forward to upcoming Ph III RCT assessing addition of RT to stimulate immune response in MSS mCRC led by Aparna Raj Parikh.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 8, 2025, 05:47
Aug 8, 2025, 05:01